Several autoimmune disease models (i.e. experimental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis (CIA)) have demonstrated that IFN-γ has the ability to downregulate symptoms of disease in animal models that use CFA in the induction of the disease [69–72]. The gene discussed is IFNG; the disease is autoimmune disease.